EuroSCORE is a good global predictor of long-term outcomes in high-risk but not in low-risk patients after unprotected left main angioplasty

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 5, 2011, Pages 625-632

  Rekik, Sofiene ^a   Brunet, Jérôme ^a   Bayet, Gilles ^a   Hager, François Xavier ^a   Meille, Laurent ^a   Quatre, Jean Michel ^a   Sainsous, Joël ^a  

^a Rhône Durance Clinic   (France)

Author keywords

angioplasty; EuroSCORE; outcome; unprotected left main disease

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BRAIN ISCHEMIA; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION; FEMALE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; REPEAT PROCEDURE; RISK ASSESSMENT; STENT THROMBOSIS; UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; STENTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953053660     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22669     Document Type: Article

References (17)

1. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 2008; 51: 172-209.
2. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R,. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13. (Pubitemid 29336425)
3. Silvestri M, Barragan P, Sainsous J, et al. Unprotected left main coronary artery stenting: Immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 2000; 35: 1543-1550. (Pubitemid 30307498)
4. Lefevre T, Morice MC, Sengottuvel G, et al. Influence of technical strategies on the outcome of coronary bifurcation stenting. EuroIntervention 2005; 1: 31-37.
5. Medina A, Suarez de Lezo J, Pan M,. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183-184.
6. Cutlip DE, Windecker S, Mehran R,et al; for the Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351. (Pubitemid 46685903)
7. Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005; 111: 791-795. (Pubitemid 40250640)
8. Romagnoli E, Burzotta F, Trani C, et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 2009; 95: 43-48.
9. Kim YH, Ahn JM, Park DW, et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 2006; 98: 1567-1570.
10. Sukiennik A, Ostrowska-Nowak J, WiÅniewska-Szmyt J, et al. Predicted and observed in-hospital mortality after left main coronary artery stenting in 204 patients. Cardiol J 2008; 15: 268-276.
11. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. (Pubitemid 40617065)
12. Garg S, Serruys PW,. Coronary angioplasty: Do we need to EuroSCORE? Nat Rev Cardiol 2009; 6: 267-268.
13. Milewski K, Wiernek S, Debinski M, et al. Early and long-term results of unprotected left main coronary artery stenting: The LE MANS (Left Main Coronary Artery Stenting) Registry. J Am Coll Cardiol 2009; 54: 1500-1511.
14. Mehilli J, Kastrati A, Byrne RA, et al. LEFT-MAIN intracoronary stenting and angiographic results: Drug-eluting stents for unprotected coronary left main lesions study investigators. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009; 53: 1760-1768.
15. Palmerini T, Barlocco F, Santarelli A, et al. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >75 years). Eur Heart J 2007; 28: 2714-2719. (Pubitemid 350135533)
16. Kim YH, Park DW, Lee SW, et al. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents. Circulation 2009; 120: 400-407.
17. Gao RL, XU B, Chen JL, et al. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: Comparison with bare-metal stent implantation. Am Heart J 2008; 155: 553-561.